CID 135508151

Pyridazinone derivative, 8e

Structural Information

Molecular Formula
C23H25N5O6S2
SMILES
CC(C)CCN1C(=O)C(=C(C(=N1)C2=CC=CS2)O)C3=NS(=O)(=O)C4=C(N3)C=CC(=C4)OC(C)C(=O)N
InChI
InChI=1S/C23H25N5O6S2/c1-12(2)8-9-28-23(31)18(20(29)19(26-28)16-5-4-10-35-16)22-25-15-7-6-14(34-13(3)21(24)30)11-17(15)36(32,33)27-22/h4-7,10-13,29H,8-9H2,1-3H3,(H2,24,30)(H,25,27)
InChIKey
BPHLZVCJUQBQLM-UHFFFAOYSA-N
Compound name
2-[[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-ylpyridazin-4-yl]-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-7-yl]oxy]propanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

5
Patents

531.12463 Da
Monoisotopic Mass

2.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 532.13191 215.3
[M+Na]+ 554.11385 222.6
[M-H]- 530.11735 218.0
[M+NH4]+ 549.15845 218.9
[M+K]+ 570.08779 216.2
[M+H-H2O]+ 514.12189 208.4
[M+HCOO]- 576.12283 218.0
[M+CH3COO]- 590.13848 242.1
[M+Na-2H]- 552.09930 213.5
[M]+ 531.12408 220.6
[M]- 531.12518 220.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe